Press Releases

Informa 2018 Survey predicts Drug Product Formulation Recognition and Budgets to increase significantly

Rentschler Biopharma and LEUKOCARE to announce findings of recent international Drug Product Formulation Survey at BIO-Europe® 2018

LEUKOCARE presenting at 12th Vaccine Congress in Budapest, Hungary

LEUKOCARE and Xellia Pharmaceuticals partner to discover innovative formulations for the development of value-added anti-infective therapies

LEUKOCARE grants a license on its SPS® formulation technology platform to Laboratorios Liomont for development and commercialization of a biosimilar

LEUKOCARE and Boehringer Ingelheim enter into a long-term agreement in the field of animal health

Rentschler Biopharma and Leukocare demonstrate success of strategic alliance for biopharmaceutical development and formulation

LEUKOCARE continues to expand and invests in research and development

Rentschler and Leukocare announce strategic alliance and equity investment

LEUKOCARE grants license to US vaccine company PaxVax